Literature DB >> 30146740

Effects of patient satisfaction and confidence on the success of treatment of combined rheumatic disease and interstitial lung disease in a multidisciplinary outpatient clinic.

Shin Ok Jeong1, Soo-Taek Uh1, Suyeon Park2, Hyun-Sook Kim1.   

Abstract

OBJECTIVES: Multidisciplinary discussions (MDDs) have emphasized improve medical services and outcomes. We used a multidisciplinary approach to explore whether patient emotional satisfaction and confidence affected treatment outcomes in rheumatic disease (RD)-related interstitial lung disease (ILD).
METHODS: From December 2015 to April 2017, we evaluated 23 patients with RD and ILD and 21 with idiopathic pulmonary fibrosis (IPF). Patients with RD and ILD were managed with MDDs. Patients with IPF received standardized medical care by the same pulmonologist. All patients completed brief multiple-choice questionnaires exploring their perceptions of their illnesses and their attitudes toward medical treatment, and completed the Patient Health Questionnaire-2.
RESULTS: The MDD patients could more easily identify disease symptoms regardless of age stratification (under 65 age: P = 0.020, 65 years or older: P = 0.003). Among the 65 years or older group, it shows higher levels of illness perception in terms of disease timeline in the MDD group (P = 0.035). Also, the MDD group reported higher levels of satisfaction in terms of the explanations they received and their involvement in discussion, and greater satisfaction with medical staff. However, the groups did not differ significantly between treatment outcomes such as changes in forced vital capacity, the diffusion capacity of carbon monoxide, or changes in high-resolution computed tomography.
CONCLUSIONS: MDDs afforded satisfactory management compared with standardized medical care. The MDD group felt better attention fromand satisfaction with medical staff, and had greater identification in their treatment. Further research engaging in MDDs with a comparable control group is required.
© 2018 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  identification; interstitial lung disease; multidisciplinary discussions; rheumatic diseases; satisfaction

Mesh:

Year:  2018        PMID: 30146740     DOI: 10.1111/1756-185X.13331

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  Clinical efficacy and safety of adalimumab versus etanercept in patients with ankylosing spondylitis and total spinal ankylosis in Croatia: a multicentre 12-month follow-up study.

Authors:  Frane Grubišić; Đurđica Babić Naglić; Porin Perić; Jadranka Morović-Vergles; Branimir Anić; Tatjana Kehler; Srđan Novak; Marino Hanih; Ana Gudelj Gračanin; Nikolina Ljubičić Marković; Simeon Grazio
Journal:  Clin Rheumatol       Date:  2022-04-18       Impact factor: 3.650

Review 2.  Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.

Authors:  Soumya Chatterjee; Apostolos Perelas; Ruchi Yadav; Donald F Kirby; Amandeep Singh
Journal:  Clin Rheumatol       Date:  2022-10-21       Impact factor: 3.650

3.  The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives.

Authors:  Federica Furini; Aldo Carnevale; Gian Luca Casoni; Giulio Guerrini; Lorenzo Cavagna; Marcello Govoni; Carlo Alberto Sciré
Journal:  Front Med (Lausanne)       Date:  2019-10-31

4.  Real-world experiences of the diagnosis process in Korean patients with ankylosing spondylitis based on a self-report questionnaire.

Authors:  Jin-Wuk Hur; Kyung Min Ko; Kyung-Su Park; Seung-Jae Hong; Hyun-Sook Kim; Myeung-Su Lee
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.